Identifying Cross-Scale Associations between Radiomic and Pathomic Signatures of Non-Small Cell Lung Cancer Subtypes: Preliminary Results.

(1) Background: Despite the complementarity between radiology and histopathology, both from a diagnostic and a prognostic perspective, quantitative analyses of these modalities are usually performed in disconnected silos. This work presents initial results for differentiating two major non-small cell lung cancer (NSCLC) subtypes by exploring cross-scale associations between Computed Tomography (CT) images and corresponding digitized pathology images. (2) Methods: The analysis comprised three phases, (i) a multi-resolution cell density quantification to identify discriminant pathomic patterns for differentiating adenocarcinoma (ADC) and squamous cell carcinoma (SCC), (ii) radiomic characterization of CT images by using Haralick descriptors to quantify tumor textural heterogeneity as represented by gray-level co-occurrences to discriminate the two pathological subtypes, and (iii) quantitative correlation analysis between the multi-modal features to identify potential associations between them. This analysis was carried out using two publicly available digitized pathology databases (117 cases from TCGA and 54 cases from CPTAC) and a public radiological collection of CT images (101 cases from NSCLC-R). (3) Results: The top-ranked cell density pathomic features from the histopathology analysis were correlation, contrast, homogeneity, sum of entropy and difference of variance; which yielded a cross-validated AUC of 0.72 ± 0.02 on the training set (CPTAC) and hold-out validation AUC of 0.77 on the testing set (TCGA). Top-ranked co-occurrence radiomic features within NSCLC-R were contrast, correlation and sum of entropy which yielded a cross-validated AUC of 0.72 ± 0.01. Preliminary but significant cross-scale associations were identified between cell density statistics and CT intensity values using matched specimens available in the TCGA cohort, which were used to significantly improve the overall discriminatory performance of radiomic features in differentiating NSCLC subtypes (AUC = 0.78 ± 0.01). (4) Conclusions: Initial results suggest that cross-scale associations may exist between digital pathology and CT imaging which can be used to identify relevant radiomic and histopathology features to accurately distinguish lung adenocarcinomas from squamous cell carcinomas.

Radiomic Texture and Shape Descriptors of the Rectal Environment on Post-Chemoradiation T2-Weighted MRI are Associated with Pathologic Tumor Stage Regression in Rectal Cancers: A Retrospective, Multi-Institution Study.

(1) Background: The relatively poor expert restaging accuracy of MRI in rectal cancer after neoadjuvant chemoradiation may be due to the difficulties in visual assessment of residual tumor on post-treatment MRI. In order to capture underlying tissue alterations and morphologic changes in rectal structures occurring due to the treatment, we hypothesized that radiomics texture and shape descriptors of the rectal environment (e.g., wall, lumen) on post-chemoradiation T2-weighted (T2w) MRI may be associated with tumor regression after neoadjuvant chemoradiation therapy (nCRT). (2) Methods: A total of 94 rectal cancer patients were retrospectively identified from three collaborating institutions, for whom a 1.5 or 3T T2w MRI was available after nCRT and prior to surgical resection. The rectal wall and the lumen were annotated by an expert radiologist on all MRIs, based on which 191 texture descriptors and 198 shape descriptors were extracted for each patient. (3) Results: Top-ranked features associated with pathologic tumor-stage regression were identified via cross-validation on a discovery set (n = 52, 1 institution) and evaluated via discriminant analysis in hold-out validation (n = 42, 2 institutions). The best performing features for distinguishing low (ypT0-2) and high (ypT3-4) pathologic tumor stages after nCRT comprised directional gradient texture expression and morphologic shape differences in the entire rectal wall and lumen. Not only were these radiomic features found to be resilient to variations in magnetic field strength and expert segmentations, a quadratic discriminant model combining them yielded consistent performance across multiple institutions (hold-out AUC of 0.73). (4) Conclusions: Radiomic texture and shape descriptors of the rectal wall from post-treatment T2w MRIs may be associated with low and high pathologic tumor stage after neoadjuvant chemoradiation therapy and generalized across variations between scanners and institutions.

Autism spectrum disorder characterization in children by capturing local-regional brain changes in MRI.

PURPOSE: To design a multiscale descriptor capable of capturing complex local-regional unfolding patterns to support quantitation and diagnosis of autism spectrum disorders (ASD) using T1-weighted structural magnetic resonance images (MRI) with voxel size of 1 × 1 × 1 mm. METHODS: The proposed image descriptor uses an adapted multiscale representation, the Curvelet transform, interpretable in terms of texture (local) and shape (regional) to characterize brain regions, and a Generalized Gaussian Distribution (GGD) to reduce feature dimensionality. In this approach, each MRI is first parcelled into 3D anatomical regions. Each resultant region is represented by a single 2D image where slices are placed next to each other. Each 2D image is characterized by mapping it to the Curvelet space and each of the different Curvelet sub-bands is described by the set of GGD parameters. To assess the discriminant power of the proposed descriptor, a classification model per brain region was built to differentiate ASD patients from control subjects. Models were constructed with support vector machines and evaluated using two samples from heterogeneous databases, namely Autism Brain Imaging Data Exchange - ABIDE I (34 ASD and 34 controls, mean age 11.46 ± 2.03 and 11.53 ± 1.79 yr, respectively, male population) and ABIDE II (42 ASD and 41 controls, mean age 10.09 ± 1.37 and 10.52 ± 1.27 yr, respectively, male population), for a total of 151 individuals. RESULTS: When the model was trained with ABIDE II sample and tested with ABIDE I on a hold-out validation, an area under receiver operator curve (AUC) of 0.69 was computed. When each sample was independently used under a cross-validation scheme, the estimated AUC was 0.75 ± 0.02 for ABIDE I and 0.77 ± 0.01 for ABIDE II. This analysis determined a set of discriminant regions widely reported in the literature as characteristic of ASD. CONCLUSIONS: The presented image descriptor demonstrated differences at local and regional level when high differences were observed in the Curvelet sub-bands. The method is simple in conceptual terms, robust to several sources of noise, and has a very low computational cost.

Differentiating Cancerous and Non-cancerous Prostate Tissue Using Multi-scale Texture Analysis on MRI.

Prostate cancer (PCa) diagnosis is established by pathological examination via biopsies, which are associated with significant complications and false negatives. Using MRIs to identify locations with high probability of containing cancer could instead be used to guide the biopsy procedure. The present investigation aims to identify target regions within different prostatic zones on MRI with high probability of being cancerous for assisting in the decision of where and how to perform biopsy. Our approach involved extracting multi-scale texture features for capturing local patterns to distinguish cancer and healthy tissue in different T2W-MRI prostate zones. Three different classification models were fed by the proposed strategy, namely support vector machine (SVM), Adaboost, and Random Forest. SVM with a linear kernel showed the best classification performance, with AUC scores of 0.91 in the anterior fibromuscular stroma area, 0.85 in the peripheral zone, and 0.87 when classification is performed independently of the prostate zone. The proposed method demonstrated that discriminant multi-scale texture features can accurately identify regions of prostate cancer in a zone-specific fashion, via MRI.